J PERS MED 润色咨询

Journal of Personalized Medicine

出版年份:暂无数据 年文章数:50 投稿命中率: 开通期刊会员,数据随心看

出版周期:Q 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=f13f16285, cover=https://img.medsci.cn/images/journal/cover/2021/kty_202109271315463500.jpg, fullname=Journal of Personalized Medicine, abbr=J PERS MED, pyear=暂无数据, frequence=Q, articleNumbers=50, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2075-4426, greenSci=https://www.greensci.net/search?kw=2075-4426, scijournal=https://www.scijournal.org/impact-factor-of-J-PERS-MED.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.053, medsciHotlight=6.013, medsciHotlight5year=1.726, citescore=3.0, hIndex=27, impactFactor=3.508, orgnization=MDPI Multidisciplinary Digital Publishing Institute, orgnizationUrl=null, country=Switzerland, countryCn=瑞典, isOa=1, isOaString=是, sciScie=BibCnrs;EBSCO;Scopus;Embase;MedSci;ProQuest;SCIE, bigclassCas=null, smallclassCas=医学 2 区, website=https://www.mdpi.com/journal/jpm, websiteHits=516, guideForAuthor=https://www.mdpi.com/journal/jpm/instructions, guideForAuthorHits=176, submitWebsite=https://susy.mdpi.com/user/manuscripts/upload?form[journal_id]=65, submitWebsiteHits=263, content=<p style="color: #222222;"><em>Journal of Personalized Medicine</em> (<em>JPM</em>; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. <em>JPM</em> publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).</p> <p style="color: #222222;">For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine,<em> JPM</em> aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.</p> <h2 style="color: #1a1a1a;"><strong>Scope</strong></h2> <p style="color: #222222;">Topics of interest with a view towards personalized medicine include (but are not limited to) the following:</p> <ul style="color: #222222;"> <li>Omics-based studies of disease risk, disease prognosis, and response to therapy</li> <li>Biomarker identification and application</li> <li>Drug target discovery and integration with individualized therapy</li> <li>Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism</li> <li>Prediction-based drug safety</li> <li>Novel therapeutics: genetic-based, nanotechnology, targeting strategies</li> <li>Advancements in Technologies and Resources</li> <ul> <li>Genetic testing, sequencing technologies, and molecular diagnostics</li> <li>Expression analysis, metabolomics, proteomics</li> <li>Microbiomes</li> <li>Genome-wide association studies</li> <li>Bioinformatics and health informatics</li> <li>Biostatistics</li> </ul> <li>Personalization of omics-based non-drug related health interventions</li> <li>Regulation and bioethics in personalized medicine</li> </ul> <h2 style="color: #1a1a1a;">Indexing & Abstracting Services</h2> <ul style="color: #222222;"> <li style="color: #222222;"><span style="color: #4f5671;">BibCnrs</span></li> <li style="color: #222222;"><span style="color: #4f5671;">CNKI</span></li> <li style="color: #222222;"><span style="color: #4f5671;">DOAJ</span></li> <li style="color: #222222;"><span style="color: #4f5671;">EBSCO</span></li> <li style="color: #222222;"><span style="color: #4f5671;">Elsevier Databases</span> <ul> <li><span style="color: #4f5671;">Scopus</span></li> <li><span style="color: #4f5671;">Embase</span></li> </ul> </li> <li style="color: #222222;"><span style="color: #4f5671;">FSTA</span></li> <li style="color: #222222;"><span style="color: #4f5671;">Gale</span></li> <li><span style="color: #4f5671;">MedSci</span></li> <li style="color: #222222;"><span style="color: #4f5671;">National Library of Medicine</span> <ul> <li><span style="color: #4f5671;">PubMed</span></li> <li><span style="color: #4f5671;">PMC</span></li> </ul> </li> <li style="color: #222222;"><span style="color: #4f5671;">OpenAIRE</span></li> <li style="color: #222222;"><span style="color: #4f5671;">OSTI (U.S. Department of Energy)</span></li> <li style="color: #222222;"><span style="color: #4f5671;">PATENTSCOPE</span></li> <li style="color: #222222;"><span style="color: #4f5671;">ProQuest</span></li> <li style="color: #222222;"><span style="color: #4f5671;">SafetyLit</span></li> <li style="color: #222222;"><span style="color: #4f5671;">Web of Science</span> <ul> <li><span style="color: #4f5671;">SCIE</span></li> <li><span style="color: #4f5671;">Current Contents - Clinical Medicine</span></li> </ul> </li> </ul>, totalCites=2964, brief=J PERS MED杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=f13f16285'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=0.792), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.386), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=7.687), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=7.134), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.053)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2075-4426[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Journal of Personalized Medicine[ta], article_number=2072, article_number_cn=108, earlyWarning=中科院(2021, 2024), linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
J PERS MED/Journal of Personalized Medicine
ISSN
2075-4426
影响指数话题
预警等级
中科院(2021, 2024)
MedSci期刊指数
6.053 (MedSci实时期刊指数) | 1.726 (5年期刊指数)
CiteScore值
3.0
h-index
27
h5-median
暂无数据
出版社/管理机构
出版国家/地区
Switzerland 瑞典
出版周期
Q
出版年份
暂无数据
是否OA
被收录情况
BibCnrs;EBSCO;Scopus;Embase;MedSci;ProQuest;SCIE
JCR分区
暂无数据
中科院分区
大类:
小类:医学 2 区